Current pharmacological solutions for Behçet’s syndrome
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2022.2155047
Abstract: ABSTRACT Introduction Behçet’s syndrome (BS) has a heterogeneous clinical phenotype, and its clinical manifestations may respond differently to drugs commonly used to treat BS. The type, dose, and duration of immunomodulatory, immunosuppressive, and biologic agents… read more here.
Keywords: current pharmacological; solutions beh; pharmacological solutions; management ... See more keywords